Roberto W. Dal Negro
- Formoterol, but not indacaterol, induces transient hypoxemia in severe COPDBy Roberto W. Dal Negro, Paola Pescatori, Claudio Micheletto and Silvia TognellaRoberto W. Dal NegroRespiratory Unit, Orlandi Hospital, Bussolengo, VR, ItalyPaola PescatoriRespiratory Unit, Orlandi Hospital, Bussolengo, VR, ItalyClaudio MichelettoRespiratory Unit, Orlandi Hospital, Bussolengo, VR, ItalySilvia TognellaRespiratory Unit, Orlandi Hospital, Bussolengo, VR, Italy
- Expert opinion on the cough hypersensitivity syndrome in respiratory medicineBy Alyn H. Morice, Eva Millqvist, Maria G. Belvisi, Kristina Bieksiene, Surinder S. Birring, Kian Fan Chung, Roberto W. Dal Negro, Peter Dicpinigaitis, Ahmad Kantar, Lorcan P. McGarvey, Adalberto Pacheco, Raimundas Sakalauskas and Jaclyn A. SmithArticle | Published in 2014 in European Respiratory JournalAlyn H. Morice1Centre for Cardiovascular and Metabolic Research, Respiratory Medicine, Hull York Medical School, University of Hull, Cottingham, UKEva Millqvist2Dept of Internal Medicine/Respiratory Medicine and Allergology, University of Gothenburg, Gothenburg, SwedenMaria G. Belvisi3Respiratory Pharmacology Group, Pharmacology and Toxicology Section, National Heart and Lung Institute, Imperial College London, London, UKKristina Bieksiene4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaSurinder S. Birring5Division of Asthma, Allergy and Lung Biology, King’s College London, London, UKKian Fan Chung6National Heart and Lung Institute, Imperial College London and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UKRoberto W. Dal Negro7Centro Nazionale Studi di Farmacoeconomia e Farmacoepidemiologua Respiratoria CESFAR, Verona, ItalyPeter Dicpinigaitis8Einstein Division/Montefiore Medical Center, Albert Einstein College of Medicine, New York, , NY, USAAhmad Kantar9Paediatric Cough and Asthma Centre, Istituti Ospedalieri Bergamaschi, Bergamo, ItalyLorcan P. McGarvey10Centre for Infection and Immunity, Queen’s University Belfast, Belfast, UKAdalberto Pacheco11Chronic Cough Unit, Pneumology Service, Hospital Ramón y Cajal, Madrid, SpainRaimundas Sakalauskas4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaJaclyn A. Smith12Centre for Respiratory and Allergy, University of Manchester, University Hospital of South Manchester, Manchester, UK
- Expert opinion on the cough hypersensitivity syndrome in respiratory medicineBy Alyn H. Morice, Eva Millqvist, Maria G. Belvisi, Kristina Bieksiene, Surinder S. Birring, Kian Fan Chung, Roberto W. Dal Negro, Peter Dicpinigaitis, Ahmad Kantar, Lorcan P. McGarvey, Adalberto Pacheco, Raimundas Sakalauskas and Jaclyn A. SmithAlyn H. Morice1Centre for Cardiovascular and Metabolic Research, Respiratory Medicine, Hull York Medical School, University of Hull, Cottingham, UKEva Millqvist2Dept of Internal Medicine/Respiratory Medicine and Allergology, University of Gothenburg, Gothenburg, SwedenMaria G. Belvisi3Respiratory Pharmacology Group, Pharmacology and Toxicology Section, National Heart and Lung Institute, Imperial College London, London, UKKristina Bieksiene4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaSurinder S. Birring5Division of Asthma, Allergy and Lung Biology, King’s College London, London, UKKian Fan Chung6National Heart and Lung Institute, Imperial College London and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UKRoberto W. Dal Negro7Centro Nazionale Studi di Farmacoeconomia e Farmacoepidemiologua Respiratoria CESFAR, Verona, ItalyPeter Dicpinigaitis8Einstein Division/Montefiore Medical Center, Albert Einstein College of Medicine, New York, , NY, USAAhmad Kantar9Paediatric Cough and Asthma Centre, Istituti Ospedalieri Bergamaschi, Bergamo, ItalyLorcan P. McGarvey10Centre for Infection and Immunity, Queen’s University Belfast, Belfast, UKAdalberto Pacheco11Chronic Cough Unit, Pneumology Service, Hospital Ramón y Cajal, Madrid, SpainRaimundas Sakalauskas4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaJaclyn A. Smith12Centre for Respiratory and Allergy, University of Manchester, University Hospital of South Manchester, Manchester, UK
- Cough hypersensitivity syndrome: clinical measurement is the key to progressBy Alyn H. Morice, Eva Millqvist, Maria G. Belvisi, Kristina Bieksiene, Surinder S. Birring, Kian Fan Chung, Roberto W. Dal Negro, Peter Dicpinigaitis, Ahmad Kantar, Lorcan P. McGarvey, Adalberto Pacheco, Raimundas Sakalauskas and Jaclyn A. SmithAlyn H. Morice1Centre for Cardiovascular and Metabolic Research, Respiratory Medicine, Hull York Medical School, University of Hull, Cottingham, UKEva Millqvist2Dept of Internal Medicine/Respiratory Medicine and Allergology, University of Gothenburg, Gothenburg, SwedenMaria G. Belvisi3Respiratory Pharmacology Group, Pharmacology and Toxicology Section, National Heart and Lung Institute, Imperial College London, London, UKKristina Bieksiene4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaSurinder S. Birring5Division of Asthma, Allergy and Lung Biology, King's College London, London, UKKian Fan Chung6National Heart and Lung Institute, Imperial College London and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UKRoberto W. Dal Negro7Centro Nazionale Studi di Farmacoeconomia e Farmacoepidemiologua Respiratoria CESFAR, Verona, ItalyPeter Dicpinigaitis8Einstein Division/Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USAAhmad Kantar9Paediatric Cough and Asthma Centre, Istituti Ospedalieri Bergamaschi, Bergamo, ItalyLorcan P. McGarvey10Centre for Infection and Immunity, Queen's University Belfast, Belfast, UKAdalberto Pacheco11Chronic Cough Unit, Pneumology Service, Hospital Ramón y Cajal, Madrid, SpainRaimundas Sakalauskas4Dept of Pulmonology and Immunology, Lithuanian University of Health Science, Kaunas, LithuaniaJaclyn A. Smith12Centre for Respiratory and Allergy, University of Manchester, University Hospital of South Manchester, Manchester, UK
- Predictive value of annual costs on 3-year mortality in COPDBy Roberto W. Dal Negro, Luca Bonadiman and Paola TurcoRoberto W. Dal Negro1National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, (CESFAR), Verona, ItalyLuca Bonadiman2National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, (CESFAR), Verona, ItalyPaola Turco3Research & Clinical Governance, Research & Clinical Governance, Verona, Italy
- Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational studyBy Roberto W. Dal Negro, Martin Iversen and Peter M.A. CalverlyRoberto W. Dal Negro1Lung Department, Orlandi General Hospital, Bussolengo, ItalyMartin Iversen1Lung Department, Orlandi General Hospital, Bussolengo, ItalyPeter M.A. Calverly1Lung Department, Orlandi General Hospital, Bussolengo, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
